Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients

Alcohol-induced Cushingoid syndrome.

with Hypaque was performed before the expected date of ovulation, and laparoscopy before menstruation.' All but one of the laparoscopies were performed under local anaesthesia2 with about 30 ml aqueous methylene blue injected under low pressure into the uterine cavity. On laparoscopy the dye could be seen traversing patent tubes and spilling into the pouch of Douglas. Bilateral tubal patency wa...

Atypical case of alcohol-induced Cushingoid syndrome.

Effect of Ganciclovir on Pharmacokinetics of Mycophenolic Mofetil, in Kidney Transplant Patients

ObjectiveMycophenolate mofetil (MMF) is commonly administered concomitantly with ganciclovir for managingtransplant recipients who infected with CMV. This study was conducted to evaluate the probable effects ofganciclovir on Mycophenolic acid (MPA) pharmacokinetic.Materials and MethodsTen kidney transplant recipients who full field inclusion and exclusion criterias enrolled in this study. Thefi...

Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients.

To assess the influence of cyclosporin A (CsA) and tacrolimus (FK506) on mycophenolic acid (MPA) and correlation analysis of the pharmacokinetic parameters and patient characteristics, clinical outcome in Chinese kidney transplant recipients, the pharmacokinetics of 1000 mg mycophenolate mofetil (MMF) twice daily was measured by high-performance liquid chromatography (HPLC). PKS (Pharmaceutical...

Plasma prednisolone measurements in renal transplant patients.

Prednisolone ('A cortisol), a synthetic glucocorticoid is widely used as an immunosuppressive in renal transplant patients. The amount given is between 50-300 mg/daily for the first few days after transplantation. This is gradually reduced over the first three months to a maintenance dose of 10-20 mg/day. The details of the schedule may vary depending on the local preference. Little is known ab...